Replay is a company developing an enzyme writing product platform for reprogramming biology by writing and delivering big DNA constructs. It offers genomic products, synthetic gene libraries leveraging, high payload delivery, and hypoimmunogenic technology services. The company also specializes in gene therapy, gene editing, transcriptional regulation, and hypo-immunogenic cell therapy.